Key result
COVID-19 lockdown measures were associated with deteriorated glycemic status and increased T2DM-related complications among 731 patients in Bangladesh.
Why the study?
COVID-19 lockdowns and shifted healthcare priorities disrupted T2DM care and clinic access in Bangladesh, where diabetes rates are rising, leaving an information gap regarding its impact.
Do COVID-19 lockdown measures worsen health outcomes in adults with Type 2 Diabetes Mellitus?
Observational (n=731)
Yes
Do COVID-19 lockdown measures worsen health outcomes in adults with Type 2 Diabetes Mellitus?
COVID-19 lockdown measures negatively impacted the glycemic control and clinical management of patients with Type 2 Diabetes in Bangladesh.
Lockdowns disrupted T2DM care in Bangladesh; leaves open resilient strategies for glycemic control in future crises.
COVID-19 lockdown measures appreciably affected patients' lifestyles, negatively impacting on their health. This includes patients with Type 2 Diabetes Mellitus (T2DM). Care of these patients was also negatively impacted due to a priority to treat patients with COVID-19, certainly initially, within hospitals and clinics in Bangladesh, combined with a lack of access to clinics and physicians due to lockdown and other measures. This is a concern in Bangladesh with growing rates of T2DM and subsequent complications. Consequently, we sought to critically analyze the situation among patients with T2DM in Bangladesh during the initial stages of the pandemic to address this information gap and provide future direction. Overall, 731 patients were recruited by a simple random sampling method among patients attending hospitals in Bangladesh, with data collected over 3 timescales: before lockdown, during the pandemic, and after lockdown. Data extracted from patients' notes included current prescribed medicines and key parameters, including blood sugar levels, blood pressure, and comorbidities. In addition, the extent of record keeping. The glycemic status of patients deteriorated during lockdown, and comorbidities as well as complications related to T2DM increased during this period. Overall, a significant proportion of key datasets were not recorded in patients' notes by their physician before and during lockdown. This started to change after lockdown measures eased. In conclusion, lockdown measures critically affected the management of patients with T2DM in Bangladesh, building on previous concerns. Extending internet coverage for telemedicine, introduction of structured guidelines, and appreciably increasing data recording during consultations is of the utmost priority to improve the care of T2DM patients in Bangladesh.
No takes yet. Share an insight, caveat, or question.
Akter et al. (2023) conducted an observational in Type 2 Diabetes Mellitus (n=731). COVID-19 lockdown measures vs. Before and after lockdown periods was evaluated on Glycemic status, comorbidities, and T2DM-related complications. COVID-19 lockdown measures were associated with deteriorated glycemic status and increased T2DM-related complications among 731 patients in Bangladesh.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: